+1 800 987 6007

As Electronic Data Capture (EDC) systems continue to advance, it’s essential to think beyond the current functionalities and explore more creative and futuristic ways these systems could transform clinical trials. This blog post proposes imaginative yet plausible advancements that could redefine how EDC systems support clinical research, making trials more efficient, adaptive, and patient-centric than ever before.

 

Augmented Reality (AR) for Clinical Trial Management

 Imagine an EDC system integrated with augmented reality technology. Clinical trial monitors and researchers could use AR glasses to see real-time data overlays when visiting trial sites or reviewing physical documents. This AR capability would allow users to instantly access patient data histories, adherence statistics, and study metrics simply by looking at a patient file or a medication package, significantly enhancing the monitoring process and ensuring protocol compliance.

Read the full blog below:

Other Guides

  • Captivate™ EDC vs. Paper Data Collection

    Time, Efficiency, and Cost | Is Paper Less Expensive than EDC?
    Historically, a common barrier to entry for implementing Electronic Data Capture (EDC) systems for small studies is the
    upfront costs, a large part of which, comes from professional services fees. Luckily, as technology has evolved, there has
    been an industry-wide shift away from legacy EDC systems, which require p...

    Read more +
  • Crossing the Final Frontier: Space Medicine and Digital Health

    Space exploration has always pushed the boundaries of human knowledge and technology, and as we venture further into the cosmos, the health and well-being of astronauts remain paramount. The unique challenges of the space environment—microgravity, radiation, isolation—demand innovative solutions for medical monitoring and care. Enter the realm of digital health technologies, which have beco...

    Read more +
  • Liquid Biopsy: The Future of Non-Invasive Cancer Diagnostics

    Liquid biopsy is an innovative and increasingly influential method in cancer diagnostics, offering significant advantages over traditional tissue biopsy by detecting cancer information through a simple blood sample. This non-invasive technique allows for the detection of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other cancer-related biomarkers in the bloodstream. In thi...

    Read more +